Philippe Bedard, Justin A. Call, Dave Garman, Edward Graeme Garmey, Paggy Hew, Ruby Lin, Patricia LoRusso, Francine Lui, Ramy Saleh, Lucas Siow, David Sommerhalder, Timothy A. Yap, Andrew Zhai, Lillian L. Siu. "Phase 1, multi-center clinical trial evaluating the safety, pharmacokinetics, pharmacodynamics and anti-cancer activity of PQ203, a first-in-class peptide drug conjugate targeting SORT1 in patients with advanced solid tumor malignancies (NCT07190469).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3171